Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials
Lathouwers, Erkki, Wong, Eric Y, Brown, Kimberley, Baugh, Bryan, Ghys, Anne, Jezorwski, John, Mohsine, El Ghazi, Van Landuyt, Erika, Opsomer, Magda, De Meyer, Sandra
Published in AIDS research and human retroviruses (01.01.2020)
Published in AIDS research and human retroviruses (01.01.2020)
Get more information
Journal Article
Week 124 results of the randomized, open-label, Phase 3 FLAIR study evaluating long-acting cabotegravir + rilpivirine for treatment in adults with HIV-1 infection
Orkin, C, D'Amico, R, Morell, E Bernal, Tan, DHS, Katner, H, Singh, Y, Stellbrink, H-J, Belonosova, E, DeMoor, R, Griffith, S, Thiagarajah, S, Solingen-Ristea, R Van, Ford, SL, Crauwels, H, Patel, P, Cutrell, A, Smith, KY, Vandermeulen, K, Clair, M St, Spreen, WR
Published in Journal of the International AIDS Society (01.07.2021)
Published in Journal of the International AIDS Society (01.07.2021)
Get full text
Journal Article